SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001363763-16-000022
Filing Date
2016-04-04
Accepted
2016-04-04 17:42:21
Documents
1
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 8389
  Complete submission text file 0001363763-16-000022.txt   9859
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Issuer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5439 LOCKHURST DRIVE WOODLAND HILLS CA 91367
Business Address
WEINGARTEN ROBERT N (Reporting) CIK: 0001135337 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16467 | Film No.: 161552132